Hematopoietic stem cell origin of mesenchymal cells: opportunity for novel therapeutic approaches Makio OgawaAmanda C. LaRueDennis K. Watson Review Article 26 March 2010 Pages: 353 - 359
Pluripotency maintenance mechanism of embryonic stem cells and reprogramming Shinji Masui Progress in Hematology 16 February 2010 Pages: 360 - 372
Differentiation of mesodermal cells from pluripotent stem cells Michinori KitagawaTakumi Era Progress in Hematology 12 March 2010 Pages: 373 - 383
Hematopoiesis from pluripotent stem cell lines Hiroshi SakamotoKiyomi Tsuji-TamuraMinetaro Ogawa Progress in Hematology 20 February 2010 Pages: 384 - 391
Pluripotent stem cells as source of dendritic cells for immune therapy Satoru SenjuShinya HirataYasuharu Nishimura Progress in Hematology 13 February 2010 Pages: 392 - 400
Transport of iron chelators and chelates across MDCK cell monolayers: implications for iron excretion during chelation therapy Xi-Ping HuangJake J. ThiessenDouglas M. Templeton Original Article 09 March 2010 Pages: 401 - 412
Hemoglobinopathy awareness among high school students in Antakya (Antioch), Turkey Nazan SavasEbru TurhanHasan Kaya Original Article 06 March 2010 Pages: 413 - 418
Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission Satoshi NishiwakiSeitaro TerakuraKoichi Miyamura Original Article 10 February 2010 Pages: 419 - 425
Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma Naoko AsanoRitsuro SuzukiShigeo Nakamura Original Article 09 March 2010 Pages: 426 - 435
Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype Philipp G. HemmatiTheis H. TerweyRenate Arnold Original Article 25 February 2010 Pages: 436 - 445
Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan Kuniaki ItohTomohiro KinoshitaMasanori Shimoyama Original Article 03 March 2010 Pages: 446 - 455
Improved treatment outcome of primary mediastinal large B-cell lymphoma after introduction of rituximab in Korean patients Hee Kyung AhnSeok Jin KimWon Seog Kim Original Article 03 March 2010 Pages: 456 - 463
A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease Chie OnishiKazuteru OhashiHisashi Sakamaki Original Article 10 March 2010 Pages: 464 - 470
Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation Hideharu MutoKazuteru OhashiHisashi Sakamaki Original Article 03 March 2010 Pages: 471 - 477
Heart rate variability during and after peripheral blood stem cell leukapheresis in autologous transplant patients and allogeneic transplant donors Takahiko NakaneHirohisa NakamaeMasayuki Hino Original Article 12 March 2010 Pages: 478 - 484
Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: participation of host immune cells Atsushi SatakeTakayuki InoueHiroyasu Ogawa Original Article 20 March 2010 Pages: 485 - 497
Vulvar squamous cell carcinoma associated with Fanconi’s anemia Azamsadat MousaviFatemeh AbbasiFarnaz Amouzegar Hashemi Case Report 10 March 2010 Pages: 498 - 500
Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis Erika IrieYuko ShirotaTomonori Ishii Case Report 10 March 2010 Pages: 501 - 508
Primary mediastinal (thymic) large B cell lymphoma with aberrant expression of CD3: a case report with review of the literature Endi WangMaggie Stoecker Case Report 04 February 2010 Pages: 509 - 515
Emergence of chronic myelogenous leukemia during treatment for essential thrombocythemia Shinsuke MizutaniJunya KurodaMasafumi Taniwaki Case Report 11 February 2010 Pages: 516 - 521
Myasthenia gravis developing in a patient with CNS lymphoma Rami MasroujehZaher K. OtrockAli Bazarbachi Case Report 09 February 2010 Pages: 522 - 524
Pediatric myeloid/NK cell precursor lymphoma/leukemia expressing T/NK immunophenotype markers Yoshiko HashiiTokuko OkudaJunichi Hara Case Report 10 February 2010 Pages: 525 - 529
A case of treatment-related myelodysplastic syndrome spontaneously resolved by drug discontinuance Yoshiko NakagawaKatsuhiro MiuraJin Takeuchi Case Report 13 February 2010 Pages: 530 - 533
Multicentric primary intestinal EBV-positive diffuse large B cell lymphoma of the elderly presenting with perforation Shih-Sung ChuangRyo IchinohasamaShu-Hui Lin Case Report 13 February 2010 Pages: 534 - 538
Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase Yasunobu NagataShiomi FukudaHideki Akiyama Case Report 27 February 2010 Pages: 539 - 541
Progressive osteosclerosis and visceral calcification after cord blood transplantation Noboru AsadaShinichi IshiiToshimitsu Matsui Case Report 17 February 2010 Pages: 542 - 545
Severe lactic acidosis, hypertriglyceridemia, and extensive axial skeleton involvement in a case of disseminated Burkitt’s lymphoma Ketan KulkarniSatvinder KaurLaxman S. Arya Letter to the Editor 09 March 2010 Pages: 546 - 548
Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype Hiromi OkadaYoshimi ToyodaTomio Yamazaki Letter to the Editor 20 March 2010 Pages: 549 - 550
A case of fatal overwhelming microgranular variant (M3v) of acute promyelocytic leukemia with extensive extramedullary involvement Claudio RomaniR. MurruE. Angelucci Letter to the Editor 09 March 2010 Pages: 551 - 552
Overcoming the effect of rifampin on the tacrolimus metabolism by itraconazole administration in an allogeneic hematopoietic stem cell transplant recipient Takehiko MoriYoshinobu AisaShinichiro Okamoto Letter to the Editor 02 March 2010 Pages: 553 - 554
Erratum to: The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases Yasumichi HitoshiNan LinVadim Markovtsov Erratum 18 March 2010 Pages: 555 - 555
